# Development and validation of a UHPLC-QqQ-MS/MS method for simultaneous determination of fifteen major components from Oroxyli seed extract in rat plasma and its application in the pharmacokinetic study

**Authors:** Zhenguo Lv, Kaili Zhang, Zijing Zhang, Jinyue Ma, Wenwen Li, Lu Chen, Wenhan Lin, Yameng Zhu, Minglei Ge, Huizi Ouyang, Jun He

PMC · DOI: 10.3389/fphar.2025.1691629 · Frontiers in Pharmacology · 2025-10-23

## TL;DR

A new method was developed to measure 15 compounds from Oroxyli seed extract in rat plasma, and it was used to study how these compounds behave in the bloodstream after oral administration.

## Contribution

A validated UHPLC-QqQ-MS/MS method for simultaneous quantification of 15 Oroxyli seed components in rat plasma was developed and applied to pharmacokinetic studies.

## Key findings

- The UHPLC-QqQ-MS/MS method was successfully validated for biological sample analysis.
- Baicalin, oroxylin A, and oroxylin A-7-O-β-D-glucuronide showed significant bimodal concentration patterns in rats.
- Baicalin reached a maximum concentration of 13376.96 ± 2232.32 ng/mL, likely due to metabolism of oroxin A and oroxin B.

## Abstract

For this investigation, a UHPLC-QqQ-MS/MS method was developed for the simultaneous determination of 15 components (chrysin, chrysin-7-O-β-D-glucuronide, hispidulin, wogonoside, quercetin, quercetin-7-O-β-D-glucoside, baicalin, baicalein, acacetin, oroxin A, oroxin B, oroxylin A, oroxylin A-7-O-β-D-glucuronide, apigenin, and scutellarein) in rat plasma. An ACQUITY UPLC BEH C18 column was utilized for separation, and simultaneous detection of the analytes was achieved through the multiple reaction monitoring mode. Method validation results were all within acceptable ranges for biological sample determination. Subsequently, the method was applied to pharmacokinetic studies in rats following oral administration of Oroxyli seed (OS) extract. The results indicated that baicalin, oroxylin A, and oroxylin A-7-O-β-D-glucuronide exhibited significant bimodal phenomena. The maximum concentration of baicalin was 13376.96 ± 2232.32 ng/mL, indicating a relatively high blood concentration. This may be related to the high content of oroxin A and oroxin B in OS extract being metabolized to baicalin. The present study may provide guidance for the further application of OS.

## Linked entities

- **Chemicals:** chrysin (PubChem CID 5281607), hispidulin (PubChem CID 5281628), wogonoside (PubChem CID 3084961), quercetin (PubChem CID 5280343), baicalin (PubChem CID 64982), baicalein (PubChem CID 5281605), acacetin (PubChem CID 5280442), oroxin A (PubChem CID 5320313), oroxin B (PubChem CID 10077207), oroxylin A (PubChem CID 5320315), apigenin (PubChem CID 5280443), scutellarein (PubChem CID 5281697)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Chemicals:** wogonoside (MESH:C473995), hispidulin (MESH:C055957), oroxylin A (MESH:C080669), baicalein (MESH:C006680), scutellarein (MESH:C458179), quercetin (MESH:D011794), OS (-), oroxin A (MESH:C000608364), oroxin B (MESH:C000604116), apigenin (MESH:D047310), acacetin (MESH:C023717), baicalin (MESH:C038044), oroxylin A-7-O-beta-D-glucuronide (MESH:C000596749), chrysin (MESH:C043561)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12589998/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12589998/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12589998/full.md

---
Source: https://tomesphere.com/paper/PMC12589998